INTESTINE Vol.20 No.5(12-1)

Series TOPICS
Title Safety and efficacy of AJM300, an oral antagonist of α4 integrin, in induction therapy for patients with active ulcerative colitis
Publish Date 2016/09
Author Naoki Yoshimura Department of Internal Medicine, Division of IBD, Tokyo Yamate Medical Center
Author Mamoru Watanabe Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
Author Satoshi Motoya Inflammatory Bowel Diseases Center, Sapporo-Kosei General Hospital
Author Keiichi Tominaga Department of Gastroenterology, Dokkyo Medical University
Author Katsuyoshi Matsuoka Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
Author Ryuichi Iwakiri Department of Internal Medicine and Gastrointestinal Endoscopy, Saga University
Author Kenji Watanabe Department of Gastroenterology, Osaka City General Hospital
Author Toshifumi Hibi Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital
Author the AJM300 Study Group the AJM300 Study Group
[ Summary ] No Summary
back